Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue
Top Cited Papers
- 1 January 2002
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 52 (1) , 6-13
- https://doi.org/10.1016/s0360-3016(01)02664-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Is the α/β ratio for prostate cancer low?International Journal of Radiation Oncology*Biology*Physics, 2001
- A simple analytic derivation suggests that prostate cancer α/β ratio is lowInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Is α/β for prostate tumors really low?International Journal of Radiation Oncology*Biology*Physics, 2001
- The definition of biochemical failure in patients treated with definitive radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Toward optimal external-beam fractionation for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont Phase II dose-escalating trialInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Fractionation and protraction for radiotherapy of prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Cell kinetic measurements in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sourcesInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationshipsInternational Journal of Radiation Oncology*Biology*Physics, 1982